Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes.
We describe a new assaying system for the detection and genotyping of human papillomavirus (HPV) based on linear-after-the-exponential-PCR(LATE-PCR) and melting curve analysis. The 23 most prevalent HPV strains (types 6, 11, 16, 18, 31, 33, 35, 39, 42, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, 81,...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0207930 |
id |
doaj-9a5705bfff484f949126243c7f150093 |
---|---|
record_format |
Article |
spelling |
doaj-9a5705bfff484f949126243c7f1500932021-03-03T21:04:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011311e020793010.1371/journal.pone.0207930Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes.Jiangfeng LyuYuefeng YuCaixia PanJing ZhouXuyi RenWe describe a new assaying system for the detection and genotyping of human papillomavirus (HPV) based on linear-after-the-exponential-PCR(LATE-PCR) and melting curve analysis. The 23 most prevalent HPV strains (types 6, 11, 16, 18, 31, 33, 35, 39, 42, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, 81, 82, and 83) are assayed in two sealed reaction tubes within 2 h. Good sensitivity and specificity was evaluated by testing cloned HPV DNA and clinical samples. The detection limit was 5-500 copies/reaction depending on the genotype. No cross-reactivity was observed with the other HPV types that are not covered by our method or pathogens tested which were commonly found in female genital tract. When compared with the HPV GenoArray Diagnostic kit, the results from 1104 clinical samples suggest good overall agreement between the two methods,(98.37%, 95% CI: 97.44%-98.97%) and the kappa value was 0.954. Overall, this new HPV genotyping assay system presents a simple, rapid, universally applicable, sensitive, and highly specific detection methodology that should be useful for HPV detection and genotyping, therefore, is potentially of great value in clinical application.https://doi.org/10.1371/journal.pone.0207930 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jiangfeng Lyu Yuefeng Yu Caixia Pan Jing Zhou Xuyi Ren |
spellingShingle |
Jiangfeng Lyu Yuefeng Yu Caixia Pan Jing Zhou Xuyi Ren Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. PLoS ONE |
author_facet |
Jiangfeng Lyu Yuefeng Yu Caixia Pan Jing Zhou Xuyi Ren |
author_sort |
Jiangfeng Lyu |
title |
Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
title_short |
Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
title_full |
Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
title_fullStr |
Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
title_full_unstemmed |
Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
title_sort |
development and validation of a method for human papillomavirus genotyping based on molecular beacon probes. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
We describe a new assaying system for the detection and genotyping of human papillomavirus (HPV) based on linear-after-the-exponential-PCR(LATE-PCR) and melting curve analysis. The 23 most prevalent HPV strains (types 6, 11, 16, 18, 31, 33, 35, 39, 42, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, 81, 82, and 83) are assayed in two sealed reaction tubes within 2 h. Good sensitivity and specificity was evaluated by testing cloned HPV DNA and clinical samples. The detection limit was 5-500 copies/reaction depending on the genotype. No cross-reactivity was observed with the other HPV types that are not covered by our method or pathogens tested which were commonly found in female genital tract. When compared with the HPV GenoArray Diagnostic kit, the results from 1104 clinical samples suggest good overall agreement between the two methods,(98.37%, 95% CI: 97.44%-98.97%) and the kappa value was 0.954. Overall, this new HPV genotyping assay system presents a simple, rapid, universally applicable, sensitive, and highly specific detection methodology that should be useful for HPV detection and genotyping, therefore, is potentially of great value in clinical application. |
url |
https://doi.org/10.1371/journal.pone.0207930 |
work_keys_str_mv |
AT jiangfenglyu developmentandvalidationofamethodforhumanpapillomavirusgenotypingbasedonmolecularbeaconprobes AT yuefengyu developmentandvalidationofamethodforhumanpapillomavirusgenotypingbasedonmolecularbeaconprobes AT caixiapan developmentandvalidationofamethodforhumanpapillomavirusgenotypingbasedonmolecularbeaconprobes AT jingzhou developmentandvalidationofamethodforhumanpapillomavirusgenotypingbasedonmolecularbeaconprobes AT xuyiren developmentandvalidationofamethodforhumanpapillomavirusgenotypingbasedonmolecularbeaconprobes |
_version_ |
1714818936411783168 |